These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32983055)

  • 1. Styrylpyridinium Derivatives as New Potent Antifungal Drugs and Fluorescence Probes.
    Vaitkienė S; Daugelavičius R; Sychrová H; Kodedová M
    Front Microbiol; 2020; 11():2077. PubMed ID: 32983055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal activity of styrylpyridinium compounds against Candida albicans.
    Vaitkienė S; Kuliešienė N; Sakalauskaitė S; Bekere L; Krasnova L; Vigante B; Duburs G; Daugelavičius R
    Chem Biol Drug Des; 2021 Feb; 97(2):253-265. PubMed ID: 32772494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
    Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
    Sanglard D; Ischer F; Calabrese D; Majcherczyk PA; Bille J
    Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Efflux Pumps and Fatty Acid Activator One Genes in Azole Resistant Candida Glabrata Isolated From Immunocompromised Patients.
    Farahyar S; Zaini F; Kordbacheh P; Rezaie S; Falahati M; Safara M; Raoofian R; Hatami K; Mohebbi M; Heidari M
    Acta Med Iran; 2016 Jul; 54(7):458-64. PubMed ID: 27424018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of antifungal resistance mediated by ABC efflux pumps from Candida albicans functionally expressed in yeast.
    Schuetzer-Muehlbauer M; Willinger B; Egner R; Ecker G; Kuchler K
    Int J Antimicrob Agents; 2003 Sep; 22(3):291-300. PubMed ID: 13678837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata.
    Sanglard D; Ischer F; Bille J
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1174-83. PubMed ID: 11257032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of azole resistance in clinical isolates of
    Yao D; Chen J; Chen W; Li Z; Hu X
    Infect Drug Resist; 2019; 12():771-781. PubMed ID: 31118695
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of Novel Schiff base Derivatives as Antifungal Compounds in Combination with Approved Drugs Against Candida Albicans.
    Malik MA; Lone SA; Gull P; Dar OA; Wani MY; Ahmad A; Hashmi AA
    Med Chem; 2019; 15(6):648-658. PubMed ID: 30501599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vacuolar proton-translocating ATPase is required for antifungal resistance and virulence of Candida glabrata.
    Minematsu A; Miyazaki T; Shimamura S; Nishikawa H; Nakayama H; Takazono T; Saijo T; Yamamoto K; Imamura Y; Yanagihara K; Kohno S; Mukae H; Izumikawa K
    PLoS One; 2019; 14(1):e0210883. PubMed ID: 30673768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata.
    Gohar AA; Badali H; Shokohi T; Nabili M; Amirrajab N; Moazeni M
    Mycopathologia; 2017 Apr; 182(3-4):273-284. PubMed ID: 27744635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in yeast plasma-membrane lipid composition affect killing activity of three families of insect antifungal peptides.
    Kodedová M; Valachovič M; Csáky Z; Sychrová H
    Cell Microbiol; 2019 Dec; 21(12):e13093. PubMed ID: 31376220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of tacrolimus and azole antifungal compounds in fluconazole-susceptible and fluconazole-resistant Candida glabrata isolates.
    Denardi LB; Mario DA; Loreto ÉS; Santurio JM; Alves SH
    Braz J Microbiol; 2015 Mar; 46(1):125-9. PubMed ID: 26221097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspofungin activity against clinical isolates of azole cross-resistant Candida glabrata overexpressing efflux pump genes.
    Posteraro B; Sanguinetti M; Fiori B; La Sorda M; Spanu T; Sanglard D; Fadda G
    J Antimicrob Chemother; 2006 Aug; 58(2):458-61. PubMed ID: 16757500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition-Disruption of
    De la Cruz-Claure ML; Cèspedes-Llave AA; Ulloa MT; Benito-Lama M; Domínguez-Álvarez E; Bastida A
    Microorganisms; 2019 Dec; 7(12):. PubMed ID: 31835290
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of genetic markers of resistance to echinocandins, azoles and 5-fluorocytosine in Candida glabrata by next-generation sequencing: a feasibility study.
    Biswas C; Chen SC; Halliday C; Kennedy K; Playford EG; Marriott DJ; Slavin MA; Sorrell TC; Sintchenko V
    Clin Microbiol Infect; 2017 Sep; 23(9):676.e7-676.e10. PubMed ID: 28344162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic interactions of sulfamethoxazole and azole antifungal drugs against emerging multidrug-resistant Candida auris.
    Eldesouky HE; Li X; Abutaleb NS; Mohammad H; Seleem MN
    Int J Antimicrob Agents; 2018 Dec; 52(6):754-761. PubMed ID: 30145250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal activity of azole compounds CPA18 and CPA109 against azole-susceptible and -resistant strains of Candida albicans.
    Calabrese EC; Castellano S; Santoriello M; Sgherri C; Quartacci MF; Calucci L; Warrilow AG; Lamb DC; Kelly SL; Milite C; Granata I; Sbardella G; Stefancich G; Maresca B; Porta A
    J Antimicrob Chemother; 2013 May; 68(5):1111-9. PubMed ID: 23292344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.